key: cord-1046251-s8o8ti8z
authors: Prasad, Megha; Leon, Martin; Lerman, Lilach O.; Lerman, Amir
title: Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19
date: 2021-08-19
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2021.06.027
sha: b58423bf6e203c7a99b0802f41abe9c09784ee5f
doc_id: 1046251
cord_uid: s8o8ti8z

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible virus with significant global impact, morbidity and mortality. The SARS-CoV-2 virus may result in widespread organ manifestations including acute respiratory distress syndrome, acute renal failure, thromboembolism, and myocarditis. Virus-induced endothelial injury may cause endothelial activation, increased permeability, inflammation, and immune response and cytokine storm. Endothelial dysfunction is a systemic disorder that is a precursor of atherosclerotic vascular disease that is associated with cardiovascular risk factors, and highly prevalent in patients with atherosclerotic cardiovascular and peripheral disease. Several studies have associated various viral infections including SARS-CoV-2 infection with inflammation, endothelial dysfunction, and subsequent innate immune response and cytokine storm. Noninvasive monitoring of endothelial function and identification of high-risk patients that may require specific therapies may have the potential to improve morbidity and mortality associated with subsequent inflammation, cytokine storm, and multi-organ involvement.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virulent and highly transmissible disease that has evolved into a pandemic with millions of infected patients. [1] [2] [3] Mechanistically, excessive inflammation, oxidation and an exaggerated immune response have been thought to be key players in the underlying pathophysiology of COVID-19. Subsequent cytokine storm and acute lung injury leading to acute respiratory distress carries significant morbidity and mortality. The SARS-CoV-2 virus infection can result in respiratory, cardiovascular, gastrointestinal and central nervous system manifestations that have been welldescribed. 4 We postulate the role of virus-induced endothelial injury and subsequent widespread endothelial dysfunction in the pathogenesis of Sars-CoV-2 infection. 5-8 SARS-CoV-2, like other viruses, may directly injure endothelial cells causing a heightened innate immune response, endothelial activation, loss of barrier function and microvascular leakage leading to dysfunction in multiple organ beds. [7] [8] [9] [10] [11] Endothelial dysfunction is a systemic disorder that is an early phase of atherosclerotic vascular disease, and thought to occur due to endothelial cell injury. 12, 13 Endothelial dysfunction has been shown to be associated with inflammation, coronary artery disease, peripheral artery disease as well as J o u r n a l P r e -p r o o f atherosclerotic risk factors including diabetes, hypertension and hyperlipidemia. [12] [13] [14] Physiologically, abnormal endothelial function results in abnormal microvascular function, impairing microvessel tone and perfusion regulation, and may result in vascular wall ischemia and neovascularization, and subsequent recruitment of macrophages, inflammation, and plaque formation. Endothelial dysfunction has been associated with significant adverse events, including both major adverse cardiovascular events and nonvascular disease such as cancer. 12, 15, 16 Several studies have associated inflammation, including both viral and nonviral inflammatory disorders, with endothelial dysfunction, and clinical sequelae spanning multiple organ systems. 13, 17, 18 Viral endothelial dysfunction While endothelial dysfunction is often a chronic process, in acute infection, viral endothelial cell injury can lead to diffuse and systemic endothelial dysfunction, and activation of multiple immune-mediated, thrombogenic and inflammatory pathways that can lead to severe multi-organ involvement, and subsequent morbidity and mortality (Figure 1 ). [19] [20] [21] [22] Figure 2 depicts viral endothelial dysfunction and its potential effect on disrupting the vascular barrier responsible for homeostasis, well described in other viral infections. A similar pathophysiologic mechanism beginning at the endothelium is likely responsible for the widespread systemic effects of SARS-CoV-2 infection. Further understanding of the role of viral endothelial dysfunction may play a role in optimizing our understanding of the pathophysiology of SARS-CoV-2 infection while improving our ability to risk-stratify J o u r n a l P r e -p r o o f and predict increased morbidity and mortality in individuals with chronic impaired endothelial function. The endothelium plays a key role in maintaining a vascular barrier and thereby controlling platelet and immune cell interactions, mediating arteriolar capillary tone, and endothelial cell adherence. Viral infection of the endothelium may cause impaired microvascular perfusion, capillary injury, thrombocytopenia, and vascular leakage. 23 Endothelial cells regulate vascular permeability and normally permit fluid transfer through a series of checks and balances to prevent lethal capillary leakage. 8 Additionally, endothelial cell adherence plays a critical part in maintaining proper endothelial function. Figure 2 depicts the effect of viruses on the endothelium if these pathways are bypassed, with resulting vascular leakage, immune cell activation and cytokine storm ( Figure   2 ). 6, 7, 19, 24 Several viruses have been previously shown to cause endothelial injury, vascular dysfunction, and widespread manifestations across multiple organ systems by disrupting normal endothelial homeostasis as described in Figure 2 . These include dengue fever, hantavirus, human immunodeficiency virus (HIV), and influenza, which have all been associated with endothelial injury leading to an inflammatory response, cytokine release and vascular leakage with varying multiorgan involvement. 20, 22, 25, 26 The dengue virus is thought to be associated with endothelial injury, which in turn leads to widespread vascular leakage evident at day 3-6 after the onset of illness. 27, 28 This timing is similar to the onset of severe illness after SARS-CoV-2 J o u r n a l P r e -p r o o f infection. The dengue virus targets dendritic cells and monocytes/macrophages which, after becoming infected, inducing release of chemokines and cytokines that activate endothelial cells, increase vascular permeability, and impair vascular function and perfusion (Figure 2) . In vitro studies have demonstrated direct infection of endothelial cells by the dengue virus leading to production of inflammatory mediators and widespread endothelial dysfunction. Additionally, excessive endothelial activation is also responsible for activation of NF-kB, another important mediator of vascular permeability. This in turns has been shown to lead to reduced multi-organ failure and morbidity and mortality. [27] [28] [29] [30] Chronic HIV infection also is widely known to be associated with endothelial dysfunction, but there is evidence that even in the acute setting HIV can result in endothelial injury and dysfunction. 22, 26, 31 In a study by Bush et al, early HIV infection was associated with early endothelial dysfunction that was reversed with the initiation of antiretroviral therapy. Moreover, persistent endothelial dysfunction was associated with delays in initiation of antiretroviral therapy further supporting a role of endothelial dysfunction in early HIV infection. 32 Mechanistically, HIV-1 proteins have been shown to dysregulate reactive oxygen species-generating enzymatic systems in the vasculature inducing microvascular impairment. HIV infection has also been associated with increased expression of adhesion molecules and inflammatory cytokines including TNF alphas and Il-6. 26, 33 Increased oxidative stress in the vascular wall may lead to an imbalance in the production of reactive oxygen species and vascular inflammation (Figure 2) . 22, 25, 32, 34 J o u r n a l P r e -p r o o f A less commonly known tick borne viral disease, severe fever with thromboycytopenia syndrome has also been associated with endothelial injury and dysfunction as evidenced by enhanced levels of several biomarkers of endothelial activation. 5, 35 Moreover, markers of endothelial dysfunction have been significantly associated with severity of disease and mortality. 35 Hantavirus, like COVID-19, is also characterized by sudden flu-like symptoms, fever, and often a hypotensive phase in which endothelial injury, Ebola virus has been shown to activate tissue factor in mononuclear phagocytes leading to an upregulation of the coagulation system, with evidence of fibrin deposits in multiple organs with evidence of proximity of infected cells and viral proteins with activated macrophages. 61 In the mice model of ARDS, the influenza virus was also shown to be associated with increased platelet aggregation, abnormal vasomotor function, microvascular pulmonary thrombosis, endothelial damage, cytokine storm and microvessel occlusion with clinical thrombosis noted. 61, 62 Trypansomoa cruzi infected mice and dogs have been shown to have occlusive thrombi and fibrin deposits in small epicardial and intramyocardial vessels as well as intramural thrombi as well.

SARS-CoV-2 infection has been associated with increased thrombosis which has led to significant morbidity and mortality. 63, 64 Infection-induced thrombosis may be associated with pre-existing risk factors including smoking, hyperlipidemia, and hypertension but whether there is direct causation is not known. 56 In certain individuals, however, it appears that infection is especially associated with thrombosis, and further identification of these risk factors may help in risk 

Acute renal failure is highly prevalent in patients with COVID-19 infection and is another important cause of major cause of morbidity and mortality. 50 Especially in patients with critical illness secondary to COVID-19 infection, it has been reported that the many patients require renal replacement therapy. 50, 65, 66 The kidney has a rich and diversified population of endothelial cells as the renal endothelium is important part of transportation across the nephron, and the endothelium must survive in extremes of oxygenation and osmolality. 66 The renal vascular endothelium may be targeted in several inflammatory processes including nephritis vasculitis, and ischemic acute renal failure. Viral induced endothelial dysfunction in the kidney may result in vasoconstriction, endothelial leakage and increased vascular permeability, tissue edema, leukocyte adhesion to the endothelial cells and microthrombosis, leading to increased renal vascular resistance which in turn alters global and regional blood flow. 57, 67, 68 Thus, during sepsis with cytokine storm, an increase in renal vascular resistance may alter global and regional blood flow contributing to changes in renal functio n. 

Myocarditis is yet another well-described manifestation of COVID-19 infection, and is also likely driven by cardiomyocyte viral infection, endothelial injury, and inflammation. 70 Myocardial thrombosis presenting as myocardial infarction has also been described. Myocarditis and myocardial thrombosis may be two separate entities, or may be pathophysiologically intertwined. 42 With viral infection, endothelial cells become injured and express adhesion molecules, antigen presenting major histocompatibility complex molecules and mount a cellular immune response leading to cardiac microvascular damage and dysfunction, diffuse myocardial inflammation, thrombus formation, and sometimes myocardial infarction. 42 In autopsy reports, several viruses including dengue virus, hantavirus, herpes simplex virus, parovirus B19, cytomegalovirus, coxsackieirus and trypanosome cruzi have been shown to infect the microvascular endothelial cells of the heart. This has also been recently seen with SARS-CoV-2 infection in several patients in whom histology revealed viral involvement of the endothelium. 71 Thus viral infection may lead to endothelial activation, damage, injury and increased J o u r n a l P r e -p r o o f permeability, causing downstream macrovascular and microvascular manifestations. 42 The increase in pro-inflammatory cytokines leads to an increase in endothelial adhesion molecules as well, which through a positive feedback mechanism may further exacerbate the infection. Ultimately, the severity of the autoimmune response to these cellular mechanisms may determine longterm prognosis. The inflammatory response secondary to SARS-CoV-2 viral infection may also cause increased vascular permeability due to enlarged intercellular gap junctions, extensive recruitment and extravasation of immune cells into the myocardium leading to myocardial edema.

In the acute phase of viral infection, viral replication occurs followed by a subacute phase during which an immune response results in a significant increase in cytokines and immune cell infiltration. 42 As the chronic phase occurs, the virus is often cleared, myocardial inflammation resolves and the myocardium remodels.

Thus, myocardial damage secondary to viral myocarditis may be secondary to the virus itself or due to the activated immune system. 42 Potential Clinical Implications Our understanding of SARS-CoV-2 infection continues to evolve since the beginning of the pandemic, however, morbidity and mortality remains high with high rates of infection and we continue to strive to understand risk factors that may predict 

The SARS-CoV-2 virus results in a severe infection with multiple organ system manifestations, leading to severe morbidity and mortality. Acute viral-induced endothelial dysfunction may be an underlying, unifying mechanism responsible for the widespread systemic manifestations seen with SARS-CoV-2 infection. Further investigation is necessary to better understand the roles of endothelial dysfunction, noninvasive assessment of endothelial function, and biomarkers of endothelial injury that may contribute to risk stratification and identifying patients prone to clinical decompensation. While our current clinical approach is to target downstream therapeutic targets and temporize with renal replacement therapy, ventilator assisted respiratory support, and medications, it is important to identify upstream pathways as therapeutic targets to be able to predict and manage harbingers of morbidity and mortality. While few robust therapies for endothelial J o u r n a l P r e -p r o o f 

Clinical Characteristics of Coronavirus Disease 2019 in China

The epidemiology, diagnosis and treatment of COVID-19

Epidemiology of Covid-19

Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study

Endothelial cell dysfunction in viral hemorrhage and edema

Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis

Acute respiratory viral infections aggravate arterial endothelial dysfunction in children with type 1 diabetes

Systemic endothelial dysfunction: A common pathway for COVID-19, cardiovascular and metabolic diseases

Severe COVID-19 infection associated with endothelial activation

Myocardial and Microvascular Injury Due to Coronavirus Disease

Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses

Endothelial dysfunction and cardiovascular disease

Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis

Elevated serum uric acid is associated with peripheral endothelial dysfunction in women

Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer

C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection

Hantavirus infection: an emerging infectious disease causing acute renal failure

Endothelial activation in ARDS

HIV-1 infection, microenvironment and endothelial cell dysfunction

Early endothelial activation precedes glycocalyx degradation and microvascular dysfunction in experimentally induced Plasmodium falciparum and Plasmodium vivax infection

HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia

Endothelial dysfunction in HIV infection

Upregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in renal tissue in severe dengue in humans: Effects on endothelial activation/dysfunction

Endothelial dysfunction in dengue virus pathology

Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination

Pathogenesis of vascular leak in dengue virus infection

HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana

Association of Endothelial Dysfunction and Antiretroviral Therapy in Early HIV Infection

Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction

Hiv Tat protein causes endothelial dysfunction in porcine coronary arteries

Endothelial activation and dysfunction in severe fever with thrombocytopenia syndrome

Zika virus modulates blood-brain barrier of brain microvascular endothelial cells

Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients

Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency

Complement-mediated Extracellular Vesicle release as a measure of endothelial dysfunction and prognostic marker for COVID-19 in peripheral blood -Letter to the Editor

Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule

Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection

Infectious myocarditis: the role of the cardiac vasculature

Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women

The role of inflammatory cytokines in endothelial dysfunction

Covid-19: risk factors for severe disease and death

Clinical features of patients infected with 2019 novel coronavirus in

Van Hemelrijck M: COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Ecancermedicalscience

Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study

The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis

Endothelial glycocalyx degradation is more severe in patients with non-pulmonary sepsis compared to pulmonary sepsis and associates with risk of ARDS and other organ dysfunction. Ann Intensive Care

Mechanisms regulating endothelial permeability

Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Oxidative stress in endothelial cell dysfunction and thrombosis

Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Infections and endothelial cells

Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19

The Role of Extracellular Histones in Influenza Virus Pathogenesis

Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models

Arterial Thrombotic Events in Adult Inpatients With COVID-19

Coronavirus Disease 2019-Associated Coagulopathy

On the Frontline of the COVID-19 Outbreak: Keeping Patients on Long-Term Dialysis Safe

Mechanism of endothelial dysfunction in chronic kidney disease

Infection-Induced Kidney Diseases

Evaluation of acute infectioninduced endothelial dysfunction and its potential mediators

Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD)

The Variety of Cardiovascular Presentations of COVID-19

Endothelial cell infection and endotheliitis in COVID-19